These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 1701788)

  • 41. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis.
    Nicolò C; Sali M; Di Sante G; Geloso MC; Signori E; Penitente R; Uniyal S; Rinaldi M; Ingrosso L; Fazio VM; Chan BM; Delogu G; Ria F
    J Immunol; 2010 Jan; 184(1):222-35. PubMed ID: 19949067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis.
    Luca ME; Kel JM; van Rijs W; Wouter Drijfhout J; Koning F; Nagelkerken L
    J Neuroimmunol; 2005 Mar; 160(1-2):178-87. PubMed ID: 15710471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein.
    van der Veen RC; Trotter JL; Clark HB; Kapp JA
    J Neuroimmunol; 1989 Feb; 21(2-3):183-91. PubMed ID: 2913045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
    al-Sabbagh A; Miller A; Santos LM; Weiner HL
    Eur J Immunol; 1994 Sep; 24(9):2104-9. PubMed ID: 7522160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
    Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
    Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
    Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
    J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
    Stohl W; Gonatas NK
    J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The magnitude of the antigen-specific T cell response is separated from the severity of spinal cord histopathology in remitting-relapsing experimental autoimmune encephalomyelitis.
    Batoulis H; Uhl M; Addicks K; Lehmann PV; Kuerten S
    Glia; 2012 May; 60(5):794-805. PubMed ID: 22319015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.
    Amor S; Groome N; Linington C; Morris MM; Dornmair K; Gardinier MV; Matthieu JM; Baker D
    J Immunol; 1994 Nov; 153(10):4349-56. PubMed ID: 7525700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells.
    Tigno-Aranjuez JT; Jaini R; Tuohy VK; Lehmann PV; Tary-Lehmann M
    J Immunol; 2009 Nov; 183(9):5654-61. PubMed ID: 19812193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental autoimmune encephalomyelitis in the maturing central nervous system. Transfer of myelin basic protein-specific T line lymphocytes to neonatal Lewis rats.
    Umehara F; Qin YF; Goto M; Wekerle H; Meyermann R
    Lab Invest; 1990 Feb; 62(2):147-55. PubMed ID: 1689408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein.
    Potter NT; Bigazzi PE
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1717-22. PubMed ID: 1373123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental allergic encephalomyelitis (EAE) in mice. I. Induction of EAE with mouse spinal cord homogenate and myelin basic protein.
    Yasuda T; Tsumita T; Nagai Y; Mitsuzawa E; Ohtani S
    Jpn J Exp Med; 1975 Oct; 45(5):423-7. PubMed ID: 57253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519.
    Vanderlugt CL; Rahbe SM; Elliott PJ; Dal Canto MC; Miller SD
    J Autoimmun; 2000 May; 14(3):205-11. PubMed ID: 10756082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M; Johnson JM; Tuohy VK
    J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fine specificity of CD4+ T cell responses to the dominant encephalitogenic PLP 139-151 peptide in SJL/J mice.
    McRae BL; Miller SD
    Neurochem Res; 1994 Aug; 19(8):997-1004. PubMed ID: 7528357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.